Abstract:Ischemic stroke (IS) is a neurological condition associated with high mortality and disability rates. Although the molecular mechanisms underlying IS remain unclear, ferroptosis was shown to play an important role in its pathogenesis. Hence, we applied bioinformatics analysis to identify ferroptosis-related therapeutic targets in IS. IS-related microarray data from the GSE61616 dataset were downloaded from the Gene Expression Omnibus (GEO) database and intersected with the FerrDb database. In total, 33 differentially expressed genes (DEGs) were obtained and subjected to functional enrichment and protein-protein interaction (PPI) network analyses. Four candidate genes enriched in the HIF-1 signaling pathway (HMOX1, STAT3, CYBB, and TLR4) were selected based on the hierarchical clustering of the PPI dataset. We also downloaded the IR-related GSE35338 dataset and GSE58294 dataset from the GEO database to verify the expression levels of these four genes. ROC monofactor analysis demonstrated a good performance of HMOX1, STAT3, CYBB, and TLR4 in the diagnosis of ischemic stroke. Transcriptional levels of the above four genes, and translational level of GPX4, the central regulator of ferroptosis, were verified in a mouse model of middle cerebral artery occlusion (MCAO)-induced IS by qRT-PCR and western blotting. Considering the regulation of the HIF-1 signaling pathway, dexmedetomidine was applied to the MCAO mice. We found that expression of these four genes and GPX4 in MCAO mice were significantly reduced, while dexmedetomidine reversed these changes. In addition, dexmedetomidine significantly reduced MCAO-induced cell death, improved neurobehavioral deficits, and reduced the serum and brain levels of inflammatory factors (TNF-α and IL-6) and oxidative stress mediators (MDA and GSSG). Further, we constructed an mRNA-miRNA-lncRNA network based on the four candidate genes and predicted possible transcription factors. In conclusion, we identified four ferroptosis-related candidate genes in IS and proposed, for the first time, a possible mechanism for dexmedetomidine-mediated inhibition of ferroptosis during IS. These findings may help design novel therapeutic strategies for the treatment of IS.

Traditional Chinese medicines derived natural inhibitors of ferroptosis on ischemic stroke

Ferroptosis in Ischemic Stroke and Related Traditional Chinese Medicines

Ferroptosis and Its Multifaceted Roles in Cerebral Stroke

Research progress of natural products for the treatment of ischemic stroke

Research Progress of Natural Products for the Treatment of Ischemic Stroke.

Progress of Ferroptosis in Ischemic Stroke and Therapeutic Targets

Potential application of traditional Chinese medicine in cerebral ischemia—Focusing on ferroptosis

Molecular mechanisms and therapeutic strategies for ferroptosis and cuproptosis in ischemic stroke

Inhibiting ferroptosis: A novel approach for stroke therapeutics

The role of ferroptosis and its mechanism in ischemic stroke

Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes

A New Perspective in the Treatment of Ischemic Stroke: Ferroptosis

Elucidating the progress and impact of ferroptosis in hemorrhagic stroke

The Regulatory Effects of Traditional Chinese Medicine on Ferroptosis

Mechanism of ferroptosis regulating ischemic stroke and pharmacologically inhibiting ferroptosis in treatment of ischemic stroke

Traditional Chinese medicines treat ischemic stroke and their main bioactive constituents and mechanisms

Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review)

Progress of medicinal plants and their active metabolites in ischemia-reperfusion injury of stroke: a novel therapeutic strategy based on regulation of crosstalk between mitophagy and ferroptosis

Research progress of traditional Chinese medicine in the treatment of ischemic stroke by regulating mitochondrial dysfunction

Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke